← brief for 2026-10-22 · Slowing decline

What is the role of sodium-glucose co-transporter protein inhibitors in managing chronic kidney disease?

Article No results yet Not peer reviewed

Key takeaways

This article reviews how a class of drugs called SGLT2 inhibitors helps people with chronic kidney disease. It says these drugs slow the loss of kidney function and lower the risk of heart problems. The text does not report new trial results, so there is no specific data to grade here.

Who did this work

Tripdatabase

Source

Article · OpenAlex, CKD works · 2026-10-21
https://doi.org/10.5281/zenodo.23539860